Tommaso Neri
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 4
- Cancer Research top 10%
- MicroRNA in disease regulation 5
-
- Pulmonary Hypertension Research and Treatments 12
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Physiology top 10%
-
- Extracellular vesicles in disease 23
-
- Blood Coagulation and Thrombosis Mechanisms 7
-
- Renin-Angiotensin System Studies 4
Tommaso Neri
54 papers receiving 926 citations
Peers
Comparison fields: 5 of 91
- Internal Medicine 44
- Cancer Research 165
- Pulmonary and Respiratory Medicine 316
- Physiology 36
- Molecular Biology 545
Countries citing papers authored by Tommaso Neri
This map shows the geographic impact of Tommaso Neri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommaso Neri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommaso Neri more than expected).
Fields of papers citing papers by Tommaso Neri
This network shows the impact of papers produced by Tommaso Neri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommaso Neri. The network helps show where Tommaso Neri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tommaso Neri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2021 | 36 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 18 | |
| 10 | 2019 | 8 | |
| 11 | 2016 | 3 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 18 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 16 | |
| 16 | 2013 | 33 | |
| 17 | 2012 | 24 | |
| 18 | 2011 | 41 | |
| 19 | 1986 | 16 | |
| 20 | [Some problems of psychiatric care unit in a general hospital I: Concerning decision of admission to hospital (author's transl)]. | 1980 | 0 |
About Tommaso Neri
Tommaso Neri is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine and Hematology, having authored 58 papers that have together received 935 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (23 papers), Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), MicroRNA in disease regulation (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Renin-Angiotensin System Studies (4 papers). The work is most often cited by research in Internal Medicine (44 citations), Cancer Research (165 citations) and Pulmonary and Respiratory Medicine (316 citations). Tommaso Neri has collaborated with scholars based in Italy, Canada and Russia. Frequent co-authors include Alessandro Celi, Roberto Pedrinelli, Pierluigi Paggiaro, Dario Nieri, Cinzia Cordazzo, Stefania Lombardi, Pierluigi Paggiaro, Sandra Brunelleschi, Claudio Bardelli and Ilaria Conti. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.